Fig. 6

Kaplan–Meier overall survival (OS) analyses of the low-risk and high-risk groups in the PSS. The high-risk group patients had a significantly worse OS than the low-risk group patients in both the primary cohort (A) and validation cohort (B)
Kaplan–Meier overall survival (OS) analyses of the low-risk and high-risk groups in the PSS. The high-risk group patients had a significantly worse OS than the low-risk group patients in both the primary cohort (A) and validation cohort (B)